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CHAPTER ONE 
 
INTRODUCTION 
 
Escherichia coli were discovered in 1885 by a pediatrician, Theodor Escherich.  
His bacteriologic studies of infant intestinal flora allowed him to characterize E. coli and 
their relation to the physiology of digestion [34]. The harmless strains of Escherichia coli 
have a habitat in the bowel of humans and animals. Their primary function in the gut is to 
provide the host with vitamin K and prevent the colonization of pathogenic bacteria. 
Pathogenic E. coli contain strains that produce toxins resulting in food poisoning. They 
can be found in the soil and contaminated water, and are generally ingested with unclean 
food or impure drink causing a gastro-intestinal infection. The strains of E. coli 
associated with infectious diseases include Enterotoxigenic E. coli (ETEC), 
Enteroinvasive E. coli (EIEC), Enterohemorrhagic E. coli (EHEC), Enteropathogenic E. 
coli (EPEC) and Uropathogenic    E. coli (UPEC) groups. For example, Enteroinvasive E. 
coli (EIEC) is found in water polluted with human feces.  The transmission usually 
occurs through hand-to-hand or hand-to-mouth in unhygienic settings and/or through 
ingestion of contaminated food.   Usually, the symptoms of bacterial infection are 
associated with mucosal abdominal pain, diarrhea, vomiting, and fever. The immunity 
against pathogenic E. coli depends on the composition of the bacterial cell surface made 
of lipopolysaccharides [32].  As a result, there have been investigations done on the
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pathways and participants involved in the production of lipopolysaccharides in different 
strains of E.coli. 
Lipopolysaccharides 
Lipopolysaccharides (LPS) are glycolipids in Gram-negative bacteria. They are 
responsible for many surface characteristics of bacterial cells including non-specific host 
defenses and the resistance to detergents, dyes and antibiotics.  LPS’s chemistry and their 
three dimensional structures prevent many compounds from crossing the outer membrane 
and gaining access to the periplasm or peptidoglycan.   Lipopolysccharides are 
amphiphilic because of a hydrophobic moiety called lipid A and the hydrophilic nature of 
saccharides.  Specifically, the backbone of lipid A consists of two β-1,6 linked 
glucosamine residues which are esterified via the hydroxyl group to fatty acids. The core 
of lipopolysccharides contains oligosaccharides which are connected to lipid A via 3-
detoxy-D-manno-octulosonate (KDO).  Lastly, O- antigens or O-polysaccharides 
projecting out of the core are carbohydrates made of repeating units of sugars (Figure 1). 
The composition of these sugars differs between strains of bacteria.  These 
oligosaccharides play a structural role in recognition sites in many biological processes 
such as antibodies, toxins, and cell recognition [33]. In this thesis, we study the role of 
UDP-Glucose Pyrophosphorylase (UDP-Glc PPase) involved in bacterial oligosaccharide 
metabolism. UDP-Glc PPase is encoded by a galU gene in both prokaryotes and 
eukaryotes.  The role of this enzyme is to produce UDP-Glucose (Uridine diphosphate 
glucose). 
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Figure 1. Arrangement of gram negative bacteria’s outer membrane. C represents 
the Core; O symbolizes oligosaccharides.  
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UDP-Glucose in Prokaryotes 
Sugar nucleotides such as UDP-Glucose play a role in constructing 
oligosaccharides in E.coli. UDP-glucose is a starting point for the production of other 
UDP-sugars such as UDP-galactose (Figure 2). One of the enzymes involved in the 
synthesis of UDP-glucose is UDP-Glucose Pyrophosphorylase (GalU).  UDP-glucose is 
also a substrate for the synthesis of UDP-glucuronic acid and required for inter-
conversion of galactose and glucose by the Leloir pathway. There has been a model 
presented for UDP-glucose production in E. coli illustrated in Figure 2 [35]. One study 
revealed that Mesophilic Aeromonas’ UDP-glucose Pyrophosphorylase (GalU) mutants 
reduced the structure of lipopolysaccharides.  Specifically, these mutants were unable to 
produce O34-antigen and resulted in reduction of pathogenic features [36].  Moreover, 
Streptococcus pneumoniae’s GalU had been reported to be essential for capsule 
formation and virulence. Acetobacter xylinum’s UDP-glucose takes part in cellulose 
synthesis which is used as a substitute for plants’ cellulose in the production of many 
commercial products such as paper and cotton textiles [9].  UDP-glucose is also involved 
in the production of disaccharides such as trehalose in gram positive bacterium, 
Corynebacterium glutamicum, which is used in a wide range of applications in the food 
industry [10].  
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Figure 2.  Model of UDP-Glucose synthesis in bacteria. Enzymes present are as 
follows: 1) glucokinase; 2) glucose-6-phosphate-1-dehydrogenase; 3) 6-
phosphogluconate dehydrogenase; 4) ribose-phosphate diphosphokinase; 5) orotate 
phosphoribosyltransferase and orotidine-5′-phosphatedecarboxylase; 6) uridylate kinase; 
7) UDP kinase; 8) phosphoglucomutase; 9) UDPglucose-4-epimerase; 10) 
lipopolysaccharide 3-alpha-galactosyltransferase 
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UDP-Glucose in Eukaryotes 
Uridine diphosphate glucose (UDP-Glucose) is one of the most important sugar 
nucleotides in higher plants [2] because it is the major glucosyl donor for carbohydrates, 
serving as the direct precursor for synthesis of sucrose.  Sucrose is a major product of 
photosynthesis in green leaves, accounting for much of CO2 fixed during day time.  UDP-
Glucose’s function in carbohydrate metabolism has not been explained thoroughly. 
However, it has been reported that UDP-Glucose may play a critical role in plant growth 
and development, at least in some species and/or during some specific developmental 
stages. For example, over-expressed bacterial UDP-Glc PPase in transgenic tobacco 
revealed an increase in growth and subsequently, increased biomass [6].  Furthermore, 
UDP-Glucose is a direct precursor for cellulose and callose synthesis occurring at the 
plasmalemma [3].   
In addition, UDP-Glucose is involved in the synthesis of carbohydrate moiety of 
glycolipids, glycoproteins and proteoglycans, among other functions [4],[5].   
In mammals, UDP-Glucose is necessary in the formation of glycogen by providing 
glucose to the progressive lengthening of the (α1→4) glycosidic chain.  Glycogen is 
primarily deposited in the liver and skeletal muscle.  Glycogen synthesis in the liver 
occurs after food intake as a consequence of the increased glucose level and serves as an 
energy supply. 
 Kinetic mechanism of UDP-Glc PPase 
 UDP-Glucose Pyrophosphorylase (EC 2.7.7.9) (UDP-Glc PPaase) is one of the 
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key enzymes of carbohydrate metabolic pathway widely found in prokaryotes and 
eukaryotes.   The enzyme catalyzes a reversible formation of uridine diphosphate glucose 
(UDP-Glc) and inorganic phosphate from Uridine 3-Phosphate (UTP) and glucose 1-
phosphate (Glc-1-P) (Figure 3). There is a single displacement of pyrophosphate from 
UTP by glucose-1-phosphate. The catalytic activity of UDP-Glc PPase appears to be 
initiated by binding of UTP or UDP-Glucose prior to the binding of glucose-1-P or PPi.  
The enzyme needs magnesium for its maximal activity [1]. 
Three dimensional structure of E. coli’s UDP-Glc PPase  
Structural analysis of UDP-Glc PPase of E. coli revealed that the protein is a 
tetramer and it can be seen as a dimer of dimers (Figure 4). Each subunit contains eight 
stranded beta sheets.  There are two additional layers of beta strands and ten alpha 
helices.  In each subunit, Pro-24 has a cis conformation. Val-37 and Asn 151 have 
dihedral angles outside of Ramachandran plot and the rest of residues appear to be in 
allowed regions of the plot. The enzyme’s subunit contains the elongated globular core 
because of present α-helices containing Phe 76-Glu 83, Arg 88-Ser 96 and additional two 
helices at C-terminus (Lys-269-Arg 282 and Gly 287-Met 298) which form the “tight 
dimer” by subunit-subunit interface [24],[25].   Interestingly, it has been noticed that the 
UDP-Glc PPase enzyme is structurally similar to glucose-1-phosphate 
thimidylyltransferase [25] and UDP-N-acetylglucosamine pyrophosphorylase [38].  In 
addition, there is lower but still significant structural similarity of UDP-Glc PPase to 
ADP-Glucose Pyrophosphorylase (ADP-Glc PPase) from bacteria (Agrobacterium 
tumefaciens), and CDP-Glucose Pyrophosphorylase from Salmonella typhi [16]. 
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Figure 3.  Kinetic mechanism of UDP-Glc PPase.  
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Figure 4.  Crystal Structure of UDP-Glc PPase tetramer (Protein Data Bank code is 
2E3D).  Subunits 1 and 4 and Subunits 2 and 3 form  a “tight” dimer meaning they 
interact with each other more than Subunits 1 and 2 and Subunits 3 and  4. 
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Important residues for the substrate binding 
There have been unsuccessful attempts to grow crystals of E. coli UDP-Glc PPase 
with the product or its substrate. Since glucose -1-phosphate thymidylytransferase was 
crystallized with its substrate and the enzyme is structurally similar to UDP-Glc PPase, 
the previous study done by Thoden group [25] was able to build a model of the UDP-Glc 
PPase’s active site.  The model had shown that Gln-109 serves to anchor the uracil ring 
through hydrogen bonding.  Furthermore, Gly-17 of UDP-Glc PPase interacts with the 2-
hydroxyl group of UDP-Glucose.   Lys-202 most likely contacts the β-phosphoryl group 
of the product while Glu-201 seemed to hydrogen bond with the 2’- and 3’-hydroxyl 
groups of the glucosyl moiety.  The same study noticed a distorted loop containing Lys- 
84, Arg -85, Val- 86 and Lys -87 close to the active site. It was hypothesized that in the 
presence of the substrate or product in UDP-Glc PPase, the enzyme closes down and the 
distorted region becomes part of the active site [25].  A three dimensional structure of 
Corynebacterium glutamicum’s UDP-Glc PPase with its product, UDP-Glucose, 
provided a more defined active site of E. coli’s UDP-Glc PPase.  Residues involved in 
anchoring the ligand to the active site include Ala-20, Gly-21, Gly-117, Gly-180 and Ala-
214 and side chains of Glu-36, Gln-112, Asp-143, Glu-201, and Lys-202. The product’s 
uracil ring hydrogen bonds to nitrogens of Ala-20 and Gly-117 and the side chain of Gln-
112 (homologous to E. coli GalU Gln-109 residue (Figure 5)).  The ribose’s 2-hydroxyl 
group hydrogen bonds to Glu-36, water and Gly-21’s nitrogen. Two magnesium ions are 
observed in the crystal structure to be coordinated to the UDP-Glucose of 
Corynebacterium glutamicum.  The glycosyl group’s 4’hydroxyl interacts with the active 
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site via nitrogen of Gly-180 and the carbonyl oxygen of Ala-214.   An α- and β- 
phosphoryl oxygen, three waters, and the side chain of Asp-142 ligate the first 
magnesium, whereas the second ion is coordinated by the α-phosphoryl oxygen and five 
waters [24]. 
In vivo regulation 
There are several levels of regulation that can be envisioned for UDP-Glc PPase. 
They involve regulation at the gene expression level (eventually having an effect on 
UDP-Glc PPase activity/protein content), but also post-translational regulation (e.g. 
protein phosphorylation).  Other regulating effects include protein interactions and direct 
inhibitory/activating effects of metabolites at the active site of the enzyme. In plants, 
abiotic stresses are important factors that affect UDP-Glc PPase’s gene expression. For 
example, UDP-Glc PPase from Arabidopsis was highly up-regulated by cold treatment at 
both mRNA and protein level [19].  Studies on barley’s UDP-Glc PPase have shown 
oligomerization as a regulatory process that affects protein function/activity. For instance, 
it has been reported that subtle changes in an immediate environment such as buffer or 
protein dilution influence oligomerization of UDP-Glc PPase [2]. In yeast, the 
localization and function of UDP-Glc PPase were found to be affected by PAS kinase-
dependent serine phosphorylation in the N-terminae domain [20].  The in vivo O-
glycosylation was reported for mammalian UDP-Glc PPase [21], however, the 
significance of this modification is not clear at this moment.   Bacterial UDP-Glc PPase 
(GalU) interacts with a GalF protein, which modulates its activity in vivo, especially 
during stress conditions [22].   
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Evolution of UDP-Glc PPase 
  All plant UDP-Glc PPases form a single monophyletic group, suggesting a single 
ancestral gene. Plant UDP-Glc PPases also have relatively high identity (39%-51%) with 
UDP-Glc PPases from the slime mold [12, 5], animals [13] and yeast [14]. However, 
eukaryotic UDP-Glc PPases are significantly divergent from those of bacterial origin, 
with very little or no identity at the amino acid sequence level [15], [2]. This may indicate 
that the genes of eukaryotic UDP-Glc PPase branched off at the very early stage of 
evolution, or that they have evolved independently. On the other hand, one study 
postulated that the Sucrose Synthase (SuSy) family in plants is homologous with bacterial 
UDP-Glc PPase. [2].    
Tissue and subcellular localization 
 
UDP-Glc PPase is required for all tissues of all living organisms and it is 
considered to be mainly localized in the cytosol. However, in some plants such as in rice 
cells had revealed the presence of UDP-Glc PPase in Golgi to some extent.  For example, 
the fractionation of rice and tobacco cells yielded some UDP-Glc PPase activity in the 
microsomes (Golgi bodies) [4].  In barley, relatively high UDP-Glc PPase activities were 
found in a membrane fraction [23].  
GalF protein      
 GalF is the protein product of the galF gene that encodes UDP-Glc 
Pyrophosphorylase.  There is no report published about the crystal structure of the GalF 
protein.  However, it has been reported that the GalF protein possibly interacts with GalU 
to control the production of UDP- Glucose.  The galF gene’s product could belong to 
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family of bacterial UDP-Glc PPases because the gene is highly conserved among 
microorganisms including Haemophilus influenzae [27] and Actobacter xylinum [28].                                           
Protein-protein interactions in vivo between GalU and GalF proteins using the 
yeast two hybrid method revealed that the GalF protein possibly interacts physically with 
GalU and regulates the biochemical and physical properties of UDP-Glc PPase.  
Specifically, the GalF protein causes reduction in the rate of phosphorylysis and provides 
a higher thermal resistance for UDP-Glc PPase by increasing in UDP-Glucose production 
[22].  It has been proposed that the GalF protein of E. coli is a non-catalytic subunit of 
UDP-Glucose Pyrophosphorylase which only physically contacts GalU to regulate the 
production of UDP-Glucose.  However, a different study reported that the galF gene 
(previously called galE) in Salmonella tryphimurium might contain some activity. But, 
the galF allele cannot produce large amount of UDP-Glucose as the galU gene. As a 
result of that, various mechanisms of interaction between these two proteins were 
hypothesized.  One hypothesis assumed that the galF gene codes for the product, UDP-
Glucose, which modifies the polypeptide determined by the galU gene by combining 
with it.  As a result, the GalF protein cannot produce an active enzyme by itself [26].
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CHAPTER TWO 
GOAL OF THIS PROJECT 
Overall goal of the project 
 Based on the UDP-Glucose Pyrophosphorylase (GalU) model with  
Corynebacterium glutamicum’s UDP-Glucose and magnesium ion, we hypothesized that  
Glutamic acid- 201, Glutamine-109, Lysine- 202, Arginine-21, Lysine-31, and Aspartic 
acid 265 are residues that play a critical role in the UDP-Glc PPase (GalU) either in 
catalysis or binding of substrates. 
 The second part of this project focused on finding whether the GalF enzyme is 
catalytic or not.   Also, the alignment of eukaryotic galU and galF amino acid sequences 
showed that Threonine-20 and Arginine-21 side chains are missing in GalF.  Therefore, 
we hypothesized that by mutating these two residues in the galF gene, GalF activity will 
be resurrected (if wild type is inactive) or mutations will increase the enzyme’s activity 
(if wild type is active). 
Part I: Biochemical exploration of UDP-Glc Pyrophosphorylase (GalU) in E.coli 
 The first part of this project investigates specific amino acids of  UDP-Glc PPase 
(GalU) that play an important role in the catalytic function. GalU’s monomer contains 
302 amino acids and has a molecular weight of 32 kDa.   In this study, we tested two 
different expression systems, pET28c and pMCSG9, and purified GalU enzymes.  We 
wanted to see which enzyme would yield a higher degree of purity.  Furthermore, to see 
15 
 
 
whether either purified wild type was significantly affected, we compared their activities 
as well as apparent binding affinities to magnesium ions.  GalU had been mutated 
previously to study potential residues that might be necessary for catalysis.  The 
mutations already studied were GalUA16V, GalUL248P and GalU P14S which had shown lack 
of synthesis of E. coli’s capsular polysaccharide.  Therefore, these three residues were 
essential for the enzyme’s activity [29].   
 The E. coli UDP-Glc PPase’s crystal structure was reported without the substrate 
[25].   Only recently the structure of Corynebacterium glutamicum was resolved with 
UDP-Glucose and two magnesium ions in the active site [24].   Therefore, we performed 
a sequence alignment of C. glutamicum UDP-Glc PPase and E. coli UDP-Glc PPase 
(Figure 5) to see which amino acids are conserved and potentially catalytic for the E.coli 
GalU enzyme. In addition, we built the model of UDP-Glc PPase with the substrate and 
one magnesium ion of C. glutamicum UDP-Glc PPase (Figure 6). The model includes 
one magnesium ion which is found in the same position among other eukaryotic UDP-
Glc PPases.  To see whether the mutagenesis will change the activity and/or substrate 
binding of E. coli’s UDP-Glc PPase, Glutamic acid- 201, Glutamine-109, Lysine- 202, 
Arginine-21, Lysine-31and Aspartic acid 265, were chosen to study in this project.
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          ....|....| ....|....| ....|....| ....|....| ....|....|  
                      10         20         30         40         50              
E.coli       ----MAAINT KVKKAVIPVA GLGTRMLPAT KAIPKEMLPL VDKPLIQYVV  
C.glutamicum MSLPIDEHVN AVKTVVVPAA GLGTRFLPAT KTVPKELLPV VDTPGIELIA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      60         70         80         90        100                      
E.coli       NECIAAGITE IVLVTHSSKN SIENHFDTSF ELEAMLEKRV KRQLLDEVQS  
C.glutamicum AEAAELGATR LAIITAPNKA GVLAHFERSS ELEETLMERG KTDQVEIIR-  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     110        120        130        140        150         
E.coli       ICPPHVTIMQ VRQGLAKGLG HAVLCAHPVV GDEP--VAVI LPDVILDEYE  
C.glutamicum RAADLIKAVP VTQDKPLGLG HAVGLAESVL DDDEDVVAVM LPDDLVLPTG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     160        170        180        190        200         
E.coli       SDLSQDNLAE MIRRFDETGH SQIMVEPVAD VTAYGVVDCK GVELAPGESV  
C.glutamicum ---VMERMAQ VRAEFGGSVL CAVEVS-EAD VSKYGIFEIE -ADTKDSDVK  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     210        220        230        240        250         
E.coli       PMVGVVEKPK ADVAPSNLAI VGRYVLSADI WPLLAKTPPG AGDEIQLTDA  
C.glutamicum KVKGMVEKPA IEDAPSRLAA TGRYLLDRKI FDALRRITPG AGGELQLTDA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     260        270        280        290        300         
E.coli       IDMLIEK-ET VEAYHMKGKS HDCGNKLGYM QAFVEYGIRH NTLGTEFKAW  
C.glutamicum IDLLIDEGHP VHIVIHQGKR HDLGNPGGYI PACVDFGLSH PVYGAQLKDA  
 
 
             ....|....| ....|....| ....|.... 
                     310        320           
E.coli       LEEEMGIKK- ---------- --------- 
C.glutamicum IKQILAEHEA AERIADDSQV KLEHHHHHH 
 
 
Figure 5.  Sequence alignment of UDP-Glc PPase (GalU) from E. coli with UDP-Glc 
PPase (GalU) from C. glutamicum.  The highlighted residues were studied in this thesis. 
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Figure 6 . Model of UDP-Glc PPase (GalU) with UDP-Glc and magnesium ion from 
C. glutamicum UDP-Glc PPase. 
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Part II: Investigation of putative UDP-Glucose Pyrophosphorylase (GalF) in E.coli 
Genes of galU and galF are similar in terms of molecular weight (approximately 
32 kD) and amino sequence lengths (galU 302 amino acids and galF 294 amino acids).  
Furthermore, the comparison of their amino acids sequences showed that they are 56.6% 
identical (Figure 7).   In the previous study done on E.coli GalF, it has been proposed that 
GalU encodes a catalytically active subunit while the GalF enzyme could serve a 
regulatory role [22].  However, the study done on S. tryphimurium GalF revealed that it 
may produce a small amount of the product, UDP-Glucose. Thus, in this project we 
attempted to purify E.coli GalF to determine GalF’s activity.  If GalF is not active or has 
a very low activity compared to GalU then there is a possibility that GalF’s and GalU’s 
common ancestor was an active subunit and GalF evolved to serve a regulatory role.  We 
tested two different expression systems, pET24a and pMCSG9, and purified GalF 
proteins to compare their activities.  In addition, we compared their apparent binding 
affinities to magnesium ions. 
In this thesis, we also mutated GalF based on the conserved regions of GalU 
proteins from bacteria and the homology model of GalF (using GalU crystal structure as a 
template).  We hypothesized that Threonine-20 and Arginine-21 side chains of GalU are 
possible critical residues that the GalF protein lost in evolution which contributed to it 
becoming non-catalytic or less-catalytic. 
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Figure 7.  Sequence alignment of E.coli’s UDP-Glc PPase from galU and galF genes
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CHAPTER THREE 
 
RESULTS AND DISCUSSION 
 
Part I:  Expression, purification and characterization of GalU 
    E. coli UDP-Glc PPase (GalU) was purified as indicated in materials and 
methods. Based on the amino acid sequence of GalU, its molecular weight is around 32 
kDa.  However, purified GalU on an SDS-PAGE showed it to be around 39 kDa (Figure 
8 and 9).  A similar weight was observed in the previous study [15]. 
GalU’s higher molecular weight value could be due to the fact that it did not bind to SDS 
(sodium dodecyl sulfate) efficiently; therefore the electrophoretic mobility was slower, 
yielding at higher apparent molecular weight than expected. Hossian group [15] predicted 
that the inefficient binding of GalU to SDS could be due to a large number of acidic 
residues present in the protein.  However, the GalF protein purified in this study has a 
similar number of acidic residues (Asp and Glu) as the GalU protein and appeared at the 
proper molecular weight on the SDS-PAGE (Figure 17).  Therefore, there must be 
another factor contributing to GalU’s higher molecular weight on the SDS-PAGE.  
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Figure 8. SDS-PAGE of GalU expressed using pET28c vector and purified using 10 
ml DEAE Sepharose column. Lanes A3-A11 show the fractions collected from DEAE 
Sepharose column.  Fractions A6 and A7 showed the greatest enzyme activity and they 
were precipitated with ammonium sulfate at 70 % saturation. 
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                                             A                                      B 
Figure 9. SDS-PAGE of GalU expressed using pMCSG9 vector and purified using 
immobilized metal ion affinity chromatography (IMAC). A)  Lane 1: prestained 
molecular mass marker; lane 2: crude extract; lane 3 indicates the flow through; lane 4 
shows the GalU enzyme (39 kDa) cleaved from the His6-MBP tag (46 kDa). B) Lane 1: 
purified GalU; lane 2: ColorPlus prestained protein marker.  The SDS-PAGE was 
prepared as described in materials and methods. 
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Kinetic analysis  
The SDS-PAGE containing all enzyme fractions of GalU (pET28c) from the 
column showed the intense protein expression in A6-A9 fractions (Figure 8).  However, 
the highest activity was observed in A6 and A7 fractions. For this reason, these two were 
combined and used for further kinetic analysis. The comparison of wild type activities 
between the combined A6-A7 fractions and GalU (pMCSG9) revealed a higher Vmax 
value or specific activity for GalU (pET28c) (Figure 10). The higher activity of fractions 
may be due to differences in stability of different expression systems or differences in 
oligomeric states of the enzyme.  The binding affinity comparison of the enzyme for 
substrates (UDP-Glc or PPi) between GalU (pET28c) and GalU (pMCSG9) did not show 
any significant differences (Figure 10).  
Since the comparison of two SDS-PAGEs (Figure 8 and 9) showed that GalU 
(pMCSG9) yielded purer GalU enzyme (Figure 9) and ensured that no endogenous 
enzyme was contaminating the sample, further experiments were performed using the 
pMCSG9 expression vector. 
Magnesium curve 
C. glutamicum UDP-Glc PPase (GalU)’s crystal structure had two magnesium 
ions present, but we included only one of them in our model [24].  The magnesium ion 
that we incorporated in our model is in the same position as in other eukaryotic UDP-Glc 
PPase’s crystal structures.  Our model of GalU with the substrate and magnesium ion 
from C. glutamicum UDP-Glc PPase (GalU) (Figure 6) showed magnesium ion to be 
around 2 Angstroms away from either Pi of UDP-Glc. Our studies indicated that 
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magnesium ions were necessary for UDP-Glc PPase’s maximum activity.   GalU 
enzymes (pET28c and pMCSG9) showed no activity in absence of magnesium ions.   
The highest activity for both GalU enzymes was observed upon minimum addition of 2 
mM of magnesium ions.  Higher concentrations of magnesium did not increase the 
activity of either UDP-Glc PPases.  Furthermore, the eznymes’ apparent binding 
affinities for magnesium ions were not significantly different from each other (Figure 
11).    
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  Vector  
Specific Activity 
(U/mg) Km (UDP-Glc), mM Km (PPi), mM 
GalU pET28c 118 0.23 ± 0.02  0.1 ± 0.01 
GalU pMCSG9 47 0.19  ± 0.01 0.10 ± 0.01 
 
 
Figure 10. Specific activity and Km comparisons of GalU enzymes. The specific 
activity was measured as described in materials and methods. 
 
 
 
 
  Vector S 0.5 (Mg2+), mM 
GalU pET28c 0.56 ± 0.03 
GalU pMCSG9 0.65 ± 0.02 
GalF pMCSG9 1.7 ± 0.3 
 
 
 
Figure 11.  S0.5 (Mg2+) comparison of GalU and GalF enzymes.  The graphs with 
different concentrations of magnesium and the corresponding binding affinities of UDP-
Glc PPases are shown in the appendix section. 
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Kinetic analysis of GalU mutants 
Based on the previously reported list of hypothetical residues involved in the 
activity of UDP-Glc PPase [24], the structural similarity of UDP-Glc PPase to ADP-Glc 
PPase and CDP- Glc PPase [16], and our model (Figure 12), six potential catalytic 
residues were studied.  Glutamic acid- 201, Glutamine-109, Lysine- 202, Arginine-21, 
Lysine-31, Aspartic acid-265 were all converted to Alanine.   
 Lysine-202 was chosen because a homologous Lysine-195 was found to be 
important for the substrate binding in ADP-Glc PPase.  Specifically, Lys-195 interacts 
with β-phosphate of the product, ADP-Glucose, and makes a salt bridge with phosphate 
of the substrate, glucose-1-phosphate.  The study done on Lys-195 in ADP-Glc PPase 
revealed that this residue affects the binding affinity for glucose-1-phosphate [41].  
Another study tested ADP-GlcPPase’s Glutamic acid-194 residue which corresponds to 
Glutamic acid-201 in E. coli UDP-Glc PPase.  The mutation, E194A, revealed that this 
residue is involved in the glucose-1-phosphate binding site.  In addition, this mutation 
had shown a 24-fold decrease in Vmax [16].  E. coli ‘s UDP-Glc PPase mutant D265A was 
chosen based on the comparison of  ADP-Glc PPase and CDP-Glc PPase active sites.  It 
had been shown that CDP-Glc PPase’s active site includes the residue D236 whereas 
ADP-Glc PPase requires D276 for activity.  D276A in ADP-Glc PPase revealed a 
decrease of 1000-fold in Vmax compared to wild type, and a 3.4 fold increase S0.5 value for 
the substrate, ATP [16]. Based on the hypothetical active site of UDP-Glc PPase and the 
comparison to ADP-Glc PPase and CDP-Glc PPase active sites, we hypothesized that the 
D265 residue might be critical in activity of UDP-Glc PPase.  
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 GalU’s Arginine-21 is one of the residues conserved among other UDP-Glc 
PPases. Our GalU enzyme model with UDP-Glc and magnesium ion from C. glutamicum 
UDP-Glc PPase showed the possibility of the Arginine-21 residue’s involvment in 
catalysis because it is pointing towards PPi part of UDP-Glucose (Figure 12).  In 
addition, the same model showed Lysine-31 to be potentially involved in activity or 
substrate binding (Figure 12).  Based on the protein/model product in one of the studies, 
it has been hypothesized that Glutamine-109 might be a residue necessary for the 
substrate binding [25].  Our model showed Glutamine-109 interacting with the Uracil 
part of UDP-Glucose, therefore this residue might be involved in UDP-Glucose binding 
(Figure 12). 
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Figure 12.  Models of GalU with UDP-Glc and magnesium ion from C. glutamicum 
UDP-Glc PPase (GalU) illustrating six residues mutated in this study. 
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The comparison of specific activities of UDP-Glc PPase constructs revealed that 
GalU- R21A is a critical catalytic residue. There was a four order of magnitude decrease 
in activity observed by GalU-R21A compared to wild type (Figure 13).  Specifically, 
GalU-R21A showed 0.003 U/mg activity compared to wild type 47 U/mg.  The variation 
of PPi (Figure 15) and UDP-Glucose concentrations (Figure 14) did not reveal significant 
affects on the binding affinity of GalU-R21A for substrates.  
The GalU-D265A and GalU-K31A constructs showed to play an important role in 
altering catalysis, yet both residues are not as critical for the maximal activity of UDP-
Glc PPase as Arginine-21 (Figure 13).  Specifically, GalU-D265A and GalU-K31A 
showed a decrease in specific activity by two and half orders of magnitude and two 
orders of magnitude respectively.  Further results showed that the GalU-K31A enzyme 
had no significant affect on the PPi or UDP-Glucose binding affinity (Figure 14 & 15).  
The binding affinities (Km) for UDP-Glucose in GalU-K31A and wild type were almost 
the same revealing 0.18 ± 0.01 mM and 0.19 ± 0.01 mM respectively. Also, Aspartic 
Acid-265 did not have an affect on the binding affinity for UDP-Glucose (Figure 14). 
However, the same residue was affecting the binding affinity for PPi (Figure 15) showing 
1.8 ± 0.3 mM compared to GalU’s Km of 0.10 ± 0.01 mM.  This result suggests some 
indirect participation of Aspartic Acid-265 in the substrate binding. 
The GalU-E201A, GalU-K202A, GalU-Q109A constructs showed the greatest 
change in affinity for UDP-Glucose binding compared to wild type and other mutants 
(Figure 14).  GalU-E201A had a Km of 1.0 ± 0.2 mM, GalU-K202A had 1.1 ± 0.3 mM 
binding affinity, and GalU-Q109A had 0.83 ± 0.06 mM compared to GalU that had Km of 
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0.19 ± 0.01 mM.  Specific activities for all three mutants were not significantly changed.  
Out of all three mutants, GalU-E201A had the highest effect on enzyme’s activity with a 
decrease of about two orders of magnitude (Figure 13).  GalU ’s E201A (Km of 0.94 ± 
0.16)  and GalU-D265A (Km of 1.8 ± 0.3) mutants showed to affect the binding of 
pyrophosphate compared to wild type (Km of 0.10 ± 0.01), which indicates that these two 
residues play a role in the binding of substrates. 
Conclusions 
 The catalytic characterization of GalU revealed a decrease in UDP-Glucose 
Pyrophosphorylase activity of all mutants. Out of all mutated residues, Arginine-21 was 
the most critical catalytic amino acid since the mutation showed the highest drop in 
activity compared to wild type. Glutamine-109 was important for the binding with Uracil, 
demonstrating its specificity for this type of enzyme.  Lysine-202 and Glutamic Acid-201 
had recognition for the sugar, UDP-glucose, but they were not important for the 
enzyme’s specificity.  Aspartic Acid-201 indirectly participated in the pyrophosphate 
binding. 
 Magnesium ions were critical for UDP-Glc PPase’s activity. Furthermore, 
approximately 2 mM was the minimal concentration of magnesium necessary for the 
enzyme’s maximal activity. 
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Figure 13.  Specific activity (Vmax) comparison of UDP-Glc PPase (GalU) constructs. 
Vmax for GalU was 47 ± 3.0 U/mg; GalU D265A 0.29 ± 0.02 U/mg; GalUK31A 0.10 ± 0.02 
U/mg;  GalUR21A 0.003 ± 0.0009;  GalUE201A 0.43 ± 0.07 U/mg;  GalUK202A 6.9 ± 0.2 
U/mg;  GalUQ109A 19 ± 2 U/mg.  The specific activities were measured as described in 
materials and methods. 
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Figure 14.   Km comparison of GalU constructs while varying UDP-Glucose 
concentrations.  The exact Km (mM) for each construct were as follows: GalU 0.19 ± 
0.01; GalU-D265A  0.09 ± 0.05; GalU-K31A 0.18 ± 0.02; GalU-R21A 0.11 ± 0.04; 
GalU-E201A 1.0 ± 0.2; GalU-K202A 1.1 ± 0.3; GalU-Q109A 0.83 ± 0.06.  The graphs 
with different concentrations of UDP-Glucose and the corresponding specific activities of  
UDP-Glc PPase constructs are shown in the appendix A section. 
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Figure 15.  Km comparison of GalU constructs while varying PPi concentrations.   
Km (mM) for GalU was 0.10 ± 0.01; 2: GalU D265A 1.8 ± 0.3; GalUK31A 0.21 ± 0.01; 
GalUR21A 0.09 ± 0.01; GalUE201A 0.94 ± 0.16; GalUK202A 0.11 ± 0.02; GalUQ109A 0.08 ± 
0.01. The graphs with different concentrations of PPi and the corresponding specific 
activities of the UDP-Glc PPase constructs are shown in the appendix A section. 
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Part II: Expression, purification and characterization of GalF  
The expression of GalF proteins (expressed in both pET24a and pMCSG9) from 
the galF gene appeared to be around 30 kDa just as predicted by amino acid sequence 
(Figure16 &17). 
Kinetic analysis 
The measurement of specific activities of GalF proteins (pET24a and pMCSG9) 
indicated that GalF is active.   Specifically, GalF (pET24a) revealed 0.02 U/mg (using 0.1 
mM PPi) activity and GalF (pMCSG9) had 0.12 U/mg (0.1 mM PPi) and 0.24 ± 0.06 
U/mg (0.5 mM PPi). The difference in activity may be due to differences in stability 
using different expression systems. Despite the fact that there was a significant difference 
in activity between GalF proteins, these results suggest that the ancestry of GalF was a 
catalytic subunit that became reduced in activity as it evolved.   
Further experiments were performed using pMCSG9 vector. 
Magnesium curve 
 Our studies indicated that magnesium ions were necessary for the maximum 
activity of GalF. The comparison of apparent binding affinities between GalF and GalU 
enzyme showed that the GalF enzyme has lower binding affinity for magnesium ions 
(Figure 11). As a result, GalF needs higher concentration of magnesium for its maximal 
activity.  Approximately 5 mM of magnesium was necessary to detect the highest activity 
of GalF. 
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Figure 16.  SDS-PAGE of GalF expressed using pET24a vector and purified using 
10 ml DEAE Sepharose column.  Lane 1 shows the prestained protein marker; Lane 2 
&3 shows GalF enzyme around 30 kDa.  
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Figure 17.  SDS-PAGE of GalF expressed using pMCSG9 vector and purified using 
immobilized metal ion affinity chromatography (IMAC).  Lane 1 represents the 
prestained protein marker; Lane 2 is a crude extract; Lane 3: the flow through; Lane 4 
indicates GalF enzyme cleaved from His6-MBP tag; Lane 5 shows pure UDP- Glc PPase 
(GalF). 
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Kinetic comparisons of GalU, GalF and GalF mutant  
Based on analysis of the active site of GalU reported in the previous study [24] 
and conserved residues among bacterial GalU proteins that are missing in GalF  
(Figure 18), the hypothetical catalytic residues were chosen to be studied in this project.   
Since the three dimensional structure of the GalF protein has not been reported yet, we 
modeled this enzyme based on the GalU’s crystal structure (Figure 19).  Also, our model 
includes the substrate and magnesium ion using C. glutamicum UDP-Glc PPase (GalU) 
as a template.  We hypothesized that mutations of Histidine-20 into Threonine and 
Methionine-21 into Arginine, could potentially resurrect the activity of GalF (if wild type 
is inactive) or increase the activity of GalF (if wild type is active).  
The specific activities and binding affinities for substrates (PPi and UDP-Glucose) 
between GalF and GalF- M15T, H16R were not changed significantly (Figure 20, 21 & 
22).  These results revealed that the two mutations on GalF had no effect on the enzyme’s 
activity and it did not affect the binding affinity for either substrate (UDP-Glc or PPi).  
Threonine and Arginine may not be the only residues that cause low activity of GalF. 
The specific activities of GalU and GalF (or GalF- M15T, H16R) showed a 100-
fold decrease for GalF.  Specifically, GalF’s Vmax was 0.24 ± 0.06 U/mg while GalU had 
the specific activity of 47 ± 3.0 U/mg (Figure 20).  Further kinetic analysis revealed that 
the GalF protein affected binding affinities for UDP-Glucose and PPi compared to the 
GalU enzyme (Figure 21, 22).   For example, the binding affinity of PPi for GalU was 
0.10 ± 0.07 mM compared to GalF that revealed 0.04 ± 0.07 mM (Figure 22).  
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                        10         20         30         40 
E. coli GalU        ----MAAINT KVKKAVIPVA GLGTRMLPAT KAIPKEMLPL 
C.glutamicum GalU   MSLPIDEHVN AVKTVVVPAA GLGTRFLPAT KTVPKELLPV 
E. coli GalF        ----MTNL-- ---KAVIPVA GLGMHMLPAT KAIPKEMLPI 
 
 
Figure 18.  UDP-Glc PPase sequence comparison.  The highlighted are the conserved 
residues of GalU proteins that are missing in GalF enzyme. 
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Figure 19.  Homology model of GalF using E. coli GalU as a template and UDP-Glc, 
magnesium ion from C. glutamicum GalU.  The model shows two residues that were 
mutated in this study. Specifically, Methionine was mutated to Threonine whereas 
Histidine was replaced by Arginine.  
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Conclusions 
 It has been reported that the galF gene does not encode an active UDP-Glc PPase, 
however, our study revealed that GalF is an active enzyme.  Yet, the protein’s specific 
activity was 100-fold lower compared to GalU.  This result suggests that the ancestry of 
GalF is a catalytic subunit and that it became reduced in activity as it evolved.  
 The saturation curve revealed that GalF needs magnesium ions in order to be 
active.  The comparison of binding affinities between GalF and GalU showed that GalF 
requires a higher concentration of magnesium in order for its maximal activity to be 
detected. The two mutations performed on the galF gene did not affect GalF’s activity 
and they did not have an effect on the binding affinity of UDP-Glc or PPi.   
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Figure 20.  Vmax  comparison of UDP-Glc PPases.  Vmax for GalU was 47 ± 3.0 U/mg; 
GalF 0.24 ± 0.06 U/mg; GalF-M15T, H16R 0.21 ± 0.09 U/mg. The specific activities 
were measured as described in materials and methods. 
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Figure 21. Km comparison of UDP-Glc PPases using different UDP-Glucose 
concentrations.  The specific Km of GalU was 0.19 ± 0.01, GalF was 0.78 ± 0.11 and 
GalFM15TH16R was 0.86 ± 0.08. The graphs with different concentrations of UDP-Glucose 
and the corresponding specific activities of UDP-Glc PPases are shown in the appendix 
A. 
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Figure 22.   Km comparison of UDP-Glc PPases using different PPi concentrations.  
GalU’s Km was 0.10 ± 0.01; Km of GalF was 0.04 ± 0.01; GalFM15H16R 0.06 ± 0.01. The 
graphs with different concentrations of PPi and the corresponding specific activities of 
UDP-Glc PPases are shown in the appendix A.
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CHAPTER FOUR 
MATERIALS AND METHODS 
Structure prediction and homology modeling 
The homology modeling was performed with the program Modeller8v2.  GalU 
and GalF models included the product UDP-Glucose and magnesium ion form C. 
glutamicum UDP-Glc PPase (PDB ID: 2PA4).  The crystal structure of GalU (PDB ID: 
2E3D) was used as a template for the GalF model. The alignment was performed using 
Bioedit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html).  The secondary structure 
prediction was performed with the PSI-PRED method [45] available on the PSI-PRED 
server (bioinfo.cs.ucl.ac.uk/psipred/) [46]. The pdb files were viewed on 
DeepView/Swiss-PDBViewer 3.7. Verification of models was performed using the  
program called Verify3D (nihserver.mbi.ucla.edu/Verify_3D/) [43].   VMD, 
 
Swiss-PdbViewer and POV-ray programs (http://www.povray.org/) were used to picture  
 
the models. The sequence alignments and Verify3D graphs can be found in the appendix 
B. 
Cloning of galU and galF genes from E. coli genome 
The cloning process was performed by Misty Khun.  XL1-Blue cells were grown 
in 5 ml Luria-Bertani (LB) Media overnight at 37 ˚C. After 12-15 hours, the cells were 
purified using the Promega’s Wizard Genomic DNA Purification Kit to obtain E. coli’s 
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genomic DNA.  Then, the DNA was digested with Hind III and Xba I restriction sites in 
order to obtain the pieces of the E. coli’s genome. These restrictions sites were chosen 
because they did not cut through galU and galF genes.  Next, TAG PCR was performed 
containing the mixture of 1 µl of digested genomic DNA, 25 µl GO-TAG Green Master 
Mix 2x, 2.5 µl of each primer and 19 µl of nanopure-di-water. The mixture was placed in 
the thermocylcer (initial denaturation of 30 seconds at 98˚C, 30 cycles of 98 ˚C for 30 
seconds, 50 ˚C for 20 seconds, 72 ˚C for 1 minute and 5 minute extension at 72 ˚C) and 
then run on the agarose gel electrophoresis 80 V for 60 minutes.  The correct size band 
for the galU gene was 906 bp while for the galF gene was 894 bp.  The galU and galF 
bands were extracted, purified, ligated into a Strataclone vector. The transformation into 
E .coli XL1-Blue cells (Stratagene) and further steps were exactly followed as described 
under Site-directed mutagenesis section. 
Primers for cloning of galU gene from E.coli genome 
Forward 5’-ATG GCT GCC ATT AAT ACG AAA GTC AAA AAA GCC GTT 
ATC CCC GTT GCG GG-3’ reverse 5’- TTA CTT CTT AAT GCC CAT CTC TTC 
TTC AAG CCA GGC TTT AAA TTC CGT GC-3’ 
Primers for cloning of galF gene from E.coli genome 
Forward: 5-ATG ACG AAT TTA AAA GCA GTT ATT CCT GTA GCG GGT 
CTC GGG ATG CAT AT-3’ and reverse: 5’-TTA TTC GCT TAA CAG CTT CTC AAT 
ACC TTT ACG GAA CTT CGC CCC TTC TT-3’
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Site-directed mutagenesis 
 The sequences of galU and galF E. coli were obtained from the GenBank 
(http://www.ncbi.nlm.nih.gov/) for visualization. The primers for galU and galF genes 
containing mutations were designed using the program called BioEdit 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html).   Site-directed mutagenesis was 
performed using Sambrook’s laboratory manual with some modifications [37].  Phusion 
PCR was performed to obtain the PCR product (mutated gene).  The PCR mixture 
contained 32.5 µl of water, 10 µl  of 5x Phusion HF buffer, 1 µl  of 10 mM dNTPs, 2.5 µl 
of primers, 0.5 µl of  DNA template (3mg/µl) and 0.5 µl  of Phusion DNA polymerase.  
The PCR mixtures were run in the thermocyler (initial denaturation of 30 seconds at 
98˚C, 30 cycles of 98 ˚C for 30 seconds, 50 ˚C for 20 seconds, 72 ˚C for 1 minute and 5 
minute extension at 72 ˚C) then the PCR products were run on agarose gel 
electrophoresis.  The correct bands were extracted, purified and another phusion PCR 
was performed using these bands as the template DNAs with the appropriate flanking 
primers.  Next, the final PCR product was ligated into a Strataclone vector and 
transformed into E .coli XL1-Blue cells (Stratagene) using the StaraClone Blunt PCR  
Cloning kit.   Transformants were plated on carbenicillin plates in the presence of X-gal 
and they were left in the incubator at 37 °C overnight for blue-white colony screening 
[37].  The presence of white colony represents a successful ligation of a vector into a 
desired gene. The mechanism is based on genetic engineering of the lac operon in the E. 
coli laboratory with a complemented subunit from the cloning vector. The vector encodes 
α subunit of LacZ protein with an internal multiple cloning site and the chromosome of
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E.coli (a host cell) encodes β-galactosidase. The DNA of interest is inserted within the 
lacZ gene which disrupts the production of β-galactosidase and appears as a white 
colony. White, bacterial colonies were picked, purified and colony PCR was performed 
[37].  Agarose gel electrophoresis analysis allowed us to verify whether the vector was 
inserted into a gene (Figure 23).  The correct band was extracted, purified and confirmed 
by DNA sequencing at University of Chicago Cancer Research Center, DNA Sequencing 
Facility. The galU and galF genes were sub-cloned into expression vectors pet28c and  
pet24a (Novagen) respectively and both of them were sub-cloned into pMCSG9 vector 
[39]                        
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Figure 23.  Example of 1.2 % agarose gel electrophoresis showing galF in 
Strataclone vector. Lane 1: 1 kb ladder; Lane 2: galF band. The correct size band for 
galFshould be around 894 bp which is approximately what is observed on the gel above.  
The galF band was extracted and purified as described in materials and methods.   
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Primers used for site-directed mutagenesis 
 
galU 
Site- directed mutagenesis was performed by PCR overlap extension using the 
procedure listed under Site Directed Mutagenesis.  galU-R21A forward (5’-TTA GGA 
ACC GCG ATG TTG CCG-3’) and reverse (5’-CGG CAA CAT CGC GGT TCC TAA-
3’), galU-K31A forward (5’-GCC ATC CCG GCG GAG ATG CTG-3’) and reverse (5’ 
CAG CAT CTC CGC CGG GAT GGC-3’), galU-Q109A forward (5’- CAA GTT CGT 
CGC GGT CTG GCG-3’) and reverse ( 5’- CGC CAG ACC CGC ACG AAC TTG-3’), 
galU-D265A forward (5’-AAG AGC CAT GCG TGC GGT AAT-3’) and reverse (5’-
ATT ACC GCA CGC ATG GCT CTT- 3’), galU-E201A forward (5’- GGT GTG GTA 
GCG AAA CCG AAA-3’) and reverse (5’ – TTT CGG TTT CGC TAC CAC ACC-3’), 
galU-K202A forward (5’-GTG GTA GAA GCG CCG AAA GCG-3’)  and reverse (5’-
CGC TTT CGG CGC TTC TAC CAC-3’).  
galF  
galF M15T H16R forward direction (5’- GGT CTC GGG ACC CGT ATG TTG 
CCT-3’) and reverse (5’-AGG CAA CAT ACG GGT CCC GAG ACC-3’). 
Flanking primers for galU and galF genes 
Forward 5’-TAA TAC GAC TCA CTA TAG GG- 3’ and reverse 5’-GCT AGT 
TAT TGC TCA GCG G-3’ 
pMCSG9 vector 
 The pMCSG9 vector [39] was used to purify the proteins of interest.  It contains a 
his6 tag bound to a maltose binding protein (MBP). The his6 tag allows the protein of 
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interest to be purified using the immobilized metal ion affinity chromatography (IMAC) 
[44].  The maltose binding protein (MBP) improves solubility and there is also a TEV-
protease site in order to cleave the protein of interest from the his6-MBP tag (Figure 24).  
The advantage of using this vector for the protein expression and purification is that it 
selectively purifies the protein containing his6-MBP tag and therefore eliminates the 
possibility to have interference with endogenous activity.  
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Figure 24. Simple model of pMCSG9 vector with the galU gene.  
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Subcloning genes into pMCSG9 vectors 
Genes of galU and galF were amplified by phusion PCR. The primers used for 
GalU wild type and mutants had the same construct. galU forward 5’- TAC TTC CAA 
TCC AAT GCC GCA GCA ATG GCT GCC ATT AAT ACG AAA GTC AAA-3’ and 
reverse 5’- TTA TCCACT TCC  AAT GTT ACT TCT TAA TGC CCA TCT CT-3’.  
GalF and galF-M15T H16R forward 5’-TAC TTC CAA TCC AAT GCC GCA GCA 
ATG ACG AAT TTA AAA GCA GTT ATT CTT-3’ and reverse 5’- TTA TCC ACT 
TCC AAT GTT ATT CGC TTA ACA GCT TCT CA-3’.  The purified PCR product 
from agarose gel electrophoresis was cloned into pMCSG9 vector [39], [40].  The gene 
was cloned into this vector using ligation independent cloning (LIC). The starting 
mixture contained 1 µl 5mM dCTP, 2 µl T4 polymerase buffer 10x, 1 µl 3mM DTT, 15 
µl of PCR gene product, 0.5 µl of water and the reaction was initiated by 0.5 µl of T4 
DNA polymerase.  The mixture was placed into a thermocycler at 25 °C for 25 minutes 
and at 75 °C for 20 minutes.  Next, the mixture was allowed to cool for 1 hour and 2 µl of 
pMCSG9 vector was added into a mixture and incubated at room temperature for 10 
minutes.   2 µl of the plasmid mix were added into 100 µl of BL21 (DE3) Magic cells and 
incubated on ice for 10 minutes.  The soc medium was added to the mix and left shaking 
for 1 hour at 37°C.  Afterwards, the cells were plated on kanamycin/ampicillin LB agar 
plates and incubated overnight at 37°C.  Next day, some colonies were picked and 
checked by using the colony PCR procedure.   
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Colony PCR procedure 
One colony from the LB agar plate was chosen by touching the colony with a 
toothpick and scratched inside the 0.2 ml PCR individual tubes.  20 µl of nuclease free 
water, 2.5 µl of the appropriate primers for the gene, and 25 µl of 2x Green Master Mix 
were added into a 0.2 ml PCR tube with a colony in it.  Next, the PCR tube with its 
contents was placed in a thermocycler using a program that starts with denaturation at 
95°C for 5 minutes, then 25 cycles of 1 minute at 95 °C, 30 s at 50 °C and 1 minute at 72 
°C with the final extension at 72 °C for 5 minutes. Then the mixture was run on 1.2 % 
agarose gel electrophoresis.  The gel was visualized with GIMP2 program and if the band 
of the gene was correct then its DNA was sequenced.   
DNA sequence visualization 
The Bioedit program was used to see DNA sequence of the gene. The  
 
program was downloaded from http://www.mbio.ncsu.edu/BioEdit/bioedit.html website. 
 
pET vector 
 
 The pET vector is used for the expression of recombinant protein in E. coli. The 
pET vector contains bacteriophage T7 transcription and translation signals, and the 
expression is induced by providing a source of T7 RNA polymerase in the host cell. The 
pET vector is good at expressing wild type protein; however it is not the best choice for 
the protein containing mutation(s).   The mutated protein expressed using pET vector 
maybe mixed with endogenous wild type.  This contamination may result in inaccurate 
mutated enzyme’s activity.  Thus, the vector containing tag such as pMCSG9 is a better 
option for expressing the mutated protein. 
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Subcloning genes into pET vectors 
 Genes of galU and galF in Strataclone vectors were digested with pET vectors 
(Novagen).  The digestion tube for galU contained buffer #1(Novagen), NcoI and SacI 
restriction enzymes obtained from NEW ENGLAND Biolabs Inc, the pET28c vector 
(http://www.genomex.com/vector_maps/pET28_map.pdf ) and galU (Strataclone). The 
digestion tube for the galF gene contained buffer #4 (Novagen), NdeI and SacI restriction 
enzymes, the pET24a vector (http://www.genomex.com/vector_maps/pet24a-d.pdf ) and 
galF (Strataclone).  The digestion contained 10:1 ratio of the gene to vector. The 
digestion tubes were placed in the water bath at 37 °C overnight.  Next, PCR clean-up 
was performed using the protocol in Wizard SV Gel and PCR Clean up system 
(Promega). Next, the quick ligation was performed by pipeting out 10 µl of the PCR 
clean up system product into a new 1.5 ml microcentrifuge tube.  10 µl of 2X quick ligase 
buffer (New England Bio Labs Inc) and 1 µl of the quick T4 DNA ligase (New England 
Bio Labs Inc) were added into 10 µl PCR product.  The mixture was briefly centrifuged 
and incubated on ice for 5 minutes. Then, 2 µl of the mixture was used to transform it 
into NEB Turbo cells (NEW England Biolabs Inc) and plated on kanamyocin plates. 
Lastly, the colony PCR was performed to check whether the vector was inserted into a 
gene. The flanking primers were used for the colony PCR for both pETgalU anf pETgalF. 
Expression and purification of GalU and GalF from pET vectors 
pETgalU and pETgalF were transformed into E. coli BL21 (DE3) cells 
(Novagen).   The single colony were grown at 37 °C in 1 liter of Luria-Bertani medium 
with kanamycin (50 µg/ml)  and shaked until an optical density of 0.6-0.7 was reached at 
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600 nm.  The culture was induced with 1M of IPTG and allowed to grow for an 
additional 16 hours at 20°C before harvesting and centrifugating (2.5 rpm for 5 minutes).  
Next, the supernatant was discarded and the pallet was sonicated in buffer A (50m M 
HEPES, pH 8.0, 5 mM MgCl2, 0.1 mM EDTA, 10% sucrose).  The solution was 
centrifuged again at 12 rpm for 20 minutes and stored at -80 °C.  The purification was 
performed at 0 to 4°C. The crude extract was applied onto 10 ml DEAE- Sepharose 
column using Akta FPLC UPC-900 (Amersham Biosciences) equilibrated in buffer A 
and the fractions were eluted with linear gradient of NaCl.  The fractions were collected 
and the enzyme was monitored by pyrophosphorolysis activity. 
Expression of GalU and GalF from pMCSG9 vectors 
Single colony of BL21 (DE3) “Magic” cells containing pMCSG9 vector were 
grown overnight at 37 °C in 5 ml LB medium containing  sterile 5 µl of 1000x ampicillin 
and 5 µl  of 1000x kanamyocin.  On the next day, the 5 ml starting culture was poured 
onto a 1ml LB medium and 1ml of 1000x ampicillin plus 1ml of 1000x kanamyocin were 
added.   The culture was grown at 25°C shaking at 250 rpm until the OD600 reached 0.6-
0.8. Next, the culture was put on ice and cooled to 16°C.  The protein was expressed by 
an addition of 0.5 mM of IPTG and left shaking at 16°C.  After around 16 hours, the cells 
were harvested by centrifugation 2.5 rpm for 5 minutes in SS34 rotor.  The cells were re-
suspended in the appropriate volume (5 ml of buffer per 1 gram of cells) of buffer C 
containing 200 mM NaCl, 20 mM Tris pH 8.0, 10% glycerol and sonicated on ice using 
the Misonix sonicator 3000 for 4 minutes total (30 seconds on, 45 seconds  off).   Lastly, 
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the cells were centrifuged in the SS34 rotor for 20 minutes with speed of 12 rpm after 
which the supernatant (crude extract) was retained and poured onto a Nickel column.  
Purification of GalU and GalF from pMCSG9 vectors 
The crude extract obtained from last centrifugation was loaded onto a Ni-NTA 
Aragose resin (Qiagen).  The Ni-NTA column with the crude extract was slowly shaken 
up and down for 1 hr so that the maximum amount of protein attaches to the resin.   Then 
the column was centrifuged at 2000 rpm for 2 min and the flow through was collected 
which was then put in -80 °C.  Next, three column volumes (15 ml) of buffer C were 
added to the Nickel column in order to wash the unbound protein. The column was then 
inverted slowly using Barnstead/Thermolyne Labquake Shaker (Rotisserie) for 5 minutes 
and the wash was collected after centrifugation (2000 rpm for 2 min).  The protein was 
eluted after the addition of combined buffer C and 300 mM of Buffer E (1 M imidazole, 
200 mM NaCl, 20 mM Tris pH 8, 10% glycerol).  Again, the column was shaken for 5 
minutes and centrifuged to obtain the protein (once the protein was eluted, the column 
needed to be washed with 3 column volumes of mixture of buffer C and 500 mM buffer 
E and 2 volume columns washes with buffer C).  The collected fraction containing the 
protein was treated with 5 mM EDTA and approximately 4 mg of TEV (tobacco Etch 
Virus) Protease stirring overnight at 4 °C.  Next, the protein was precipitated with 
ammonium sulfate of 60 % saturation and centrifuged to remove any imidazole. The 
protein was re-suspended in buffer C (200 mM NaCl, 20 mM Tris pH 8.0, 10% glycerol) 
and loaded onto a Ni-NTA resin. The column was shaken up and down for 1 hr, 
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centrifuged and the elute (protein) was collected.  Afterwards, the column was washed 
with buffer C and higher concentration of buffer E as described above.   
Measuring protein concentration 
The concentration of purified protein was measured using a NanoDrop ND-1000 
Spectrophotometer with an extinction coefficient of 1 AU/mg-1 ml-1.  The procedure was 
exactly performed as provided by the manufacturer.  The module displays the UV 
spectrum and measures the protein’s absorbance at 280 nm to calculate the concentration 
in mg/ml automatically.  
SDS-PAGE preparation  
Electrophoresis was performed using 1.5 mm cassette. The separation gel was 
made from 3.125 ml of 40% of acrylamide, 4.7 ml of separating gel buffer (1M Tris-HCl, 
pH 8.8), 125 µl of 10% SDS, 125 µl of catalyst ( 0.1 g Ammonium Persulfate in 960 µl 
of water), 2 ml of 50% sucrose, 5 µl  of TEMED and 2.55 ml of water.  Next, n-butanol 
was poured onto the top of separating gel to eliminate any bubbles formed.  The gel was 
left for a while until it hardened. Then the gel was flushed with de-ionized-nanopure 
water to remove the excess of n-butanol. The stocking gel was poured onto the separating 
gel. The mixture of stocking gel included 0.4 ml of 40% acylamide, 1.56 ml stocking gel 
buffer (0.5 M Tris-Hcl pH 6.8),  62.2 µl  of 10% SDS, 0.25 ml of catalyst (0.1 g 
Ammonium Persulfate in 960 µl of water), 2.5 µl  of TEMED and 4 ml of water.   The 
sample containing 5-10 µl of crude extract or fraction after purification was mixed with 
2-Mercaptoethanol, 2x sample buffer (stocking buffer, glycerol, 10% SDS, water, 0.2 % 
bromophenol blue and 2-Mercaptoethanol) and run on the thermocycler for 10 minutes.  
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Afterwards, the samples were loaded onto the gel and run for 60 minutes, 200 Volts.  The 
1X Tris-HEPES-SDS (Invitrogen) buffer was used for electrophoresis.  The New 
England Biolabs prestained protein marker broad range was used to estimate protein’s 
molecular weight.  The gel was stained with Pierce (Rockford, IL, USA) Gel Code Blue 
Stain Reagent. 
Enzyme assay: Pyrophosphorolysis direction  
 
The UDP- Glucose Pyrophosphorylase activity was measured in the reverse 
direction (Pyrophosphorolysis), from UDP-glucose and PPi to Glucose-1-P and UTP.  
The reaction mixture (300 µl) contained 80 mM HEPES at 8.0 pH,  7 mM of MgCl2,  2 
mM of DTT, 0.5 mM of UDP- glucose, 0.6 mM of NAD+ , 10 mM of NaF, 0.01 mM of 
G1,6BP,  2 U/ml of PGM (Phosphoglucomutase preparation from Rabbit muscle), 2 U/ml 
of G6PDH (glucose-6-phosphate dehydrogenase form Leuconostoc mesenter),  
0.2 mg/ml of bovine serum albumin, de-ionized-nanopure water and 10 µl of enzyme.  
The reaction was initiated by the addition of 0.5 mM of NaPPI and placed into the 
spectrophotometer (BioTek EL 808) (Figure 24). 
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Figure 25.  Spectrophotometric coupled enzyme essay of UDP-
Glucose in the pyrophosphorolysis directrion.  The essay 
monitors enzyme activity. 
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Calculation of kinetic constants 
 
 The kinetic assays were performed at optimal conditions for all reaction mixtures.  
The data was plotted for different concentrations of PPi (mM) on x-axis versus the 
activity (nmol/min) on y-axis.  Then, we used Origin 7.5 program which contains the 
modified Hill equation for a non-linear curve fit, V = Vo + (Vmax - Vo) * sn / (kn  +  sn) 
[42]. V is the velocity while Vmax is the maximum velocity at saturation. S symbolizes the 
substrate and k is the amount of substrate concentration needed to obtain 50% maximum 
velocity.  We varied Vmax and k parameters to get the best possible fit.  The same process 
was used for the data with variation of UDP-Glucose (mM).
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KINETIC GRAPHS OF UDP-GLC PPASES 
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GalU (pMCSG9): varying [Mg2+] 
Conditions: 50 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.98966 
START 0 0 
END 1.8819 0.02842 
k 0.65024 0.02462 
n 2.59794 0.23154 
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GalU (pMCSG9): varying [UDP-Glc] 
 
Conditions: 25 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99271 
START 0 0 
END 1.24149 0.02428 
k 0.19139 0.01371 
n 1 0 
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GalU (pMCSG9): varying [PPi] 
 
Conditions: 25 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99345 
START 0 0 
END 1.04998 0.02703 
k 0.10099 0.00718 
n 1.8 0 
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GalU (pET28c): varying [Mg2+] 
 
Conditions: 30 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.97692 
START 0 0 
END 2.54289 0.05167 
k 0.55861 0.03137 
n 2.43611 0.30328 
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GalU (pET28c): varying [UDP-Glc] 
 
Conditions: 7.4 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99738 
START 0 0 
END 2.29102 0.05896 
k 0.22878 0.01513 
n 1 0 
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GalU (pET28c): varying [PPi] 
 
Conditions: 7.4 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99548 
START 0 0 
END 1.57189 0.03174 
k 0.10048 0.00619 
n 1.4 0 
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GalU D265A: varying [UDP-Glc] 
 
Conditions: 9.4 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.90523 
START 0 0 
END 1.67659 0.1209 
k 0.09162 0.04779 
n 0.4 0 
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GalU D265A: varying [PPi] 
 
Conditions: 47 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99755 
START 0 0 
END 19.42007 2.44702 
k 1.82909 0.32501 
n 1 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 
 
 
GalU K31A: varying [UDP-Glc] 
 
Conditions: 9.4 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.97347 
START 0 0 
END 0.8706 0.03074 
k 0.17859 0.02361 
n 1 0 
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GalU K31A: varying [PPi] 
 
Conditions: 28 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99659 
START 0 0 
END 3.65974 0.0912 
k 0.20532 0.01227 
n 1.6 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72 
 
 
GalU R21A: varying [UDP-Glc] 
 
Conditions: 12 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods 
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. 
Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.82161 
 START 0 0 
END 0.03205 0.00235 
k 0.11306 0.03823 
n 1.3 0 
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GalU R21A: varying [PPi] 
 
Conditions: 24 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.97648 
START 0 0 
END 0.07584 0.00348 
k 0.089 0.01469 
n 1 0 
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GalU K202A: varying [UDP-Glc] 
 
Conditions: 39 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.97609 
START 0 0 
END 0.52169 0.06211 
k 1.12752 0.27321 
n 1 0 
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GalU K202A: varying [PPi] 
 
Conditions: 39 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.98586 
START 0 0 
END 0.33377 0.01384 
k 0.11105 0.01561 
n 1 0 
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GalU Q109A: varying [UDP-Glc] 
 
Conditions: 12 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99734 
START 0 0 
END 0.42744 0.01363 
k 0.82958 0.06004 
n 1 0 
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GalU Q109A: varying [PPi] 
 
Conditions: 12 ng of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99208 
START 0 0 
END 0.41432 0.0101 
k 0.08016 0.00722 
n 1 0 
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GalU E201A: varying [UDP-Glc] 
 
Conditions: 0.6 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.98497 
START 0 0 
END 0.72592 0.06097 
k 1.01564 0.18022 
n 1 0 
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GalU E201A: varying [PPi] 
 
Conditions: 0.6 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.9947 
START 0 0 
END 1.12592 0.1132 
k 0.94202 0.16175 
n 1 0 
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GalF (pMCSG9): varying [Mg2+] 
 
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.97854 
START 0 0 
END 1.23893 0.12313 
k 1.72281 0.30192 
n 1.3944 0.2195
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GalF (pMCSG9): varying [UDP-Glc] 
 
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99058 
START 0 0 
END 2.90082 0.17342 
k 0.77778 0.10799 
n 1 0 
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GalF (pMCSG9): varying [PPi] 
 
Conditions: 4.4 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.95832 
START 0 0 
END 1.08417 0.04363 
k 0.04131 0.00705 
n 1.1 0 
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GalF M15T H16R (pMCSG9): varying [UDP-Glc] 
 
Conditions: 3 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.99508 
START 0 0 
END 1.7037 0.07415 
k 0.85466 0.08357 
n 1 0 
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GalF M15T H16R (pMCSG9): varying [PPi] 
 
Conditions: 3 µg of the protein, Temperature: 30 °C, other conditions are the same as 
described under the enzyme assay section in materials and methods. 
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Equation: y = START + (END - START) * x^n  /  (k^n  +  x^n) 
R^2 =  0.98422 
START 0 0 
END 0.71189 0.02271 
k 0.06112 0.00775 
n 1 0
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APPENDIX B: 
 
SUPLEMENTARY INFORMATION ABOUT PROTEIN MODELS
86 
 
 
Sequence alignment for the GalF model 
 
1) galug[newline]structureX:galug: 138: A: 264: A:undefined:undefined:-1.00:-1.00; 2) 
galuu [newline]structureX:galuu: 5: A: 298: A:undefined:undefined:-1.00:-1.00; 3) 2pa4a 
[newline]structureX:2pa4a: 12: A: 326: A:undefined:undefined:-1.00:-1.00; 4) GALF 
[newline]sequence:GALF: : : : :::-1.00:-1.001 
 
 
 
87 
 
 
Verify3D graph for the GalF model 
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Sequence alignment for the GalU model 
 
1) galug[newline]structureX:galug: 138: A: 264: A:undefined:undefined:-1.00:-1.00; 2) 
galuu [newline]structureX:galuu: 5: A: 298: A:undefined:undefined:-1.00:-1.00; 3) 2pa4a 
[newline]structureX:2pa4a: 12: A: 326: A:undefined:undefined:-1.00:-1.00; 4) galu 
[newline]sequence:galu: : : : :::-1.00:-1.001 
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Verify3D graph for the GalU model 
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